# IXCHIQ (ixchiq) PDUFA date and FDA approval status

Canonical: https://sec-api.dev/pdufa/ixchiq

> The FDA approved IXCHIQ (ixchiq), sponsored by Valneva SE (VALN), on April 14, 2025.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: month only, exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Key facts

| Field | Value |
| --- | --- |
| Drug | IXCHIQ (ixchiq) |
| Codes |  |
| Sponsor | Valneva SE (VALN) https://sec-api.dev/companies/valn/catalysts |
| Indications |  |
| Modality |  |
| FDA designations | none disclosed |

## Timeline

### Jan 2024: trial start

- Status: completed. Date confidence: month. Stage: 2.
- First seen 2025-03-24, last confirmed 2026-03-17.
- SEC Form 10-K (accession 0001628280-26-018808): "In January 2024, we initiated a Phase 2 pediatric trial in children one to eleven years of age to evaluate the safety and immunogenicity of two different dose levels of IXCHIQ." https://www.sec.gov/Archives/edgar/data/1836564/000162828026018808/valn-20251231.htm
- SEC Form 10-K (accession 0001628280-25-014522): "In January 2024, we initiated a Phase 2 pediatric trial in children one to eleven years of age to evaluate the safety and immunogenicity of two different dose levels of IXCHIQ." https://www.sec.gov/Archives/edgar/data/1836564/000162828025014522/valn-20241231.htm

### January 21, 2025: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-01-21, last confirmed 2025-01-23.
- Press release filed with the SEC (EX-99) (accession 0001628280-25-002290): "11 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025002290/valnevapr22-1x25.htm
- Press release filed with the SEC (EX-99) (accession 0001628280-25-001948): "12 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025001948/valnevapr20-1x25.htm

### February 5, 2025: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-02-05, last confirmed 2025-02-05.
- Press release filed with the SEC (EX-99) (accession 0001628280-25-003919): "2 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025003919/valnevapr5-2x2025.htm

### February 28, 2025: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-02-28, last confirmed 2025-02-28.
- Press release filed with the SEC (EX-99) (accession 0001628280-25-008984): "6 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ®" https://www.sec.gov/Archives/edgar/data/1836564/000162828025008984/valnevapr28-2x25.htm

### March 20, 2025: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-03-20, last confirmed 2025-03-24.
- Press release filed with the SEC (EX-99) (accession 0001628280-25-014459): "2 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ®" https://www.sec.gov/Archives/edgar/data/1836564/000162828025014459/valnevapr24-3x25.htm
- Press release filed with the SEC (EX-99) (accession 0001628280-25-013977): "11 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025013977/valnevapr3-20x2025.htm

### March 31, 2025: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-03-31, last confirmed 2025-04-01.
- Press release filed with the SEC (EX-99) (accession 0001628280-25-015897): "[2] Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025015897/valnevapr4-1x2025.htm
- Press release filed with the SEC (EX-99) (accession 0001628280-25-015535): "3 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025015535/valnevapr31-3x2025.htm

### April 14, 2025: FDA approval

- Status: completed, approved. Date confidence: exact.
- First seen 2025-04-14, last confirmed 2025-04-16.
- Press release filed with the SEC (EX-99) (accession 0001628280-25-017969): "5 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025017969/valnevapr2025_04x16xwvc2025.htm
- Press release filed with the SEC (EX-99) (accession 0001628280-25-017639): "3 Valneva Announces U.S. FDA Approval of World's First Chikungunya Vaccine, IXCHIQ® - Valneva" https://www.sec.gov/Archives/edgar/data/1836564/000162828025017639/valnevapr14-4x2025.htm

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/pdufa/ixchiq.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "IXCHIQ (ixchiq) PDUFA date and FDA approval status." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/pdufa/ixchiq

```bibtex
@misc{secapidev_pdufa_ixchiq_20261116,
  title        = {IXCHIQ (ixchiq) PDUFA date and FDA approval status},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/pdufa/ixchiq}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_pdufa_ixchiq_20261116","title":"IXCHIQ (ixchiq) PDUFA date and FDA approval status","publisher":"sec-api.dev","URL":"https://sec-api.dev/pdufa/ixchiq","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
